This randomised control trial sponsored by the British Heart Foundation assessed whether transdermal glyceryl trinitrate (GTN) is beneficial to patients experiencing a stroke.

The trial completed recruitment in May 2018, and the results were published in February 2019 in The Lancet (RIGHT-2); Pre-hospital treatment with GTN for patients with presumed stroke does not appear to improve functional outcome.

For more information, please visit the trial website: http://right-2.ac.uk/

Participating Ambulance Services:

East of England Ambulance Service
East Midlands Ambulance Service
London Ambulance Service
North West Ambulance Service
West Midlands Ambulance Service
Yorkshire Ambulance Service

If you’d like to work with ambulance services from across the UK to develop a similar project contact us.